To overcome the challenges associated with Dox chemotherapy, uPAR-targeted dual drugs co-encapsulated nanoparticles (NPs), carrying Dox and curcumin (CUR), were constructed to treat lung cancer, using the uPAR-targeting peptide U11 [244,245]. This evidence concerns the gene PLAUR and lung carcinoma.